Advanced Search

 

Study ID Status Title Patient Level Data
204838 Not yet recruiting A study to evaluate safety, reactogenicity and immunogenicity of GSK Biologicals’ RSV investigational vaccine based on viral proteins encoded by chimpanzee-derived adenovector (ChAd155-RSV) (GSK3389245A) in RSV-seropositive infants
204847 Recruiting A Phase I, Randomized, Double-Blind (Sponsor Unblinded), Single-Center, Placebo-Controlled, Two-Part Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Ascending Single and Repeat Intravenous Doses of GSK3342830 in Healthy Adult Subjects
204851 Recruiting A multi-centre Phase IIa double-blind, placebo-controlled study to investigate the efficacy and safety of GSK3196165 in subjects with inflammatory hand osteoarthritis
204853 Completed A Microdose Study to Describe the Intravenous Pharmacokinetics of GSK3191607 in Healthy Male Subjects Following Administration of [14C]-GSK3191607
204856 Recruiting A Phase I, Randomized, Placebo-Controlled, Double-Blind (sponsor unblind), Three Part Study to Evaluate the Safety, Tolerability, Preliminary PK and PD of Single and Repeat Oral Doses of GSK3008356 in Healthy Subjects and Obese Subjects
204857 Completed An Open-label Single-Center, 4-Period William’s Cross-Over Design Drug Interaction Trial to Determine the Effects of Sorbitol-Containing Solutions on Lamivudine Exposure Following Administration of Lamivudine Oral Solution in Healthy Adult Subjects
204860 Recruiting A double-blind (sponsor unblinded) study to investigate safety, tolerability, pharmacokinetics, pharmacodynamics and clinical effect of repeat dosing of GSK2646264 in cutaneous lupus erythematosus patients
204870 Completed A Clinical Study to Evaluate the Efficacy of an Experimental Mouthwash Formulation
204879 Recruiting A Randomized, Open-label, Active-Controlled, Parallel-Group, Exploratory Study on the Effects of Repeated Doses of Albiglutide compared to Exenatide on Gastric Myoelectrical Activity and Gastric Emptying in Subjects with Type 2 Diabetes Mellitus
204885 Not yet recruiting Skin Acceptability Assessment of the cosmetic product SM Peach Beige, in subjects with all Skin Types Under Normal Usage Conditions
204888 Not yet recruiting HO-15-15503 - Qualitative Interviews and Survey: Understanding how the attributes of Relvar/Breo convey patient benefits – Asthma and COPD
204890 Not yet recruiting Skin Acceptability Assessment of the cosmetic product SM Translucent, in subjects with all Skin Types Under Normal Usage Conditions.
204891 Not yet recruiting Skin Acceptability Assessment of the cosmetic product SM Light Beige, in subjects with all Skin Types Under Normal Usage Conditions.
204892 Not yet recruiting Skin Acceptability Assessment of the cosmetic product SB Translucent, in subjects with all Skin Types Under Normal Usage Conditions.
204896 Not yet recruiting Skin Acceptability Assessment of the cosmetic product SM Medium Beige, in subjects with all Skin Types Under Normal Usage Conditions.
204897 Not yet recruiting Skin Acceptability Assessment of the cosmetic product SB Peach Beige, in subjects with all Skin Types Under Normal Usage Conditions.
204898 Not yet recruiting Skin Acceptability Assessment of the cosmetic product SB Light Beige, in subjects with all Skin Types Under Normal Usage Conditions
204899 Not yet recruiting Skin Acceptability Assessment of the cosmetic product SB-Medium Beige, in subjects with all Skin Types Under Normal Usage Conditions.
204900 Completed PGx7642: Meta-analysis of data from FCGR PGx evaluations of ofatumumab CLL studies OMB110911, OMB114242, OMB115991 and OMB110913
204901 Completed PGx7644: Meta-analysis of data from SLE patients treated with Benlysta in studies BEL112341, BEL110752/BLISS-52/C1056, and BEL110751/BLISS-76/C1057
204905 Not yet recruiting Skin Acceptability Assessment of the cosmetic product SM Light Beige, in subjects with sensitive skin Under Normal Usage Conditions.
204906 Not yet recruiting Skin Acceptability Assessment of the cosmetic product SM Medium Beige, in subjects with sensitive skin Under Normal Usage Conditions
204907 Withdrawn Skin Acceptability Assessment of the cosmetic product SM Translucent, in subjects with sensitive skin Under Normal Usage Conditions
204908 Not yet recruiting Skin Acceptability Assessment of the cosmetic product SM Peach Beige, in subjects with sensitive skin Under Normal Usage conditions
204917 Not yet recruiting Comedogenic and acnegenic potential evaluation with ophthalmologic evaluation of the cosmetic product SB Translucent - in-use study.

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.